Aripiprazole Tablet
Product Images NDC 60687-179

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 60687-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg Aripiprazole Tablet Blister

Aripiprazole Tablet USP 10 mg packaging label from American Health Packaging. The label includes product name, strength (10 mg), dosage form (tablet), lot number 123456, and expiration date 05/17. A barcode is also present on the label.*

FDA Label Image

10 mg Aripiprazole Tablets Carton

Label for Aripiprazole Tablets, USP 10 mg oral tablets. The label indicates a package size of 100 tablets (10 blister packs of 10 tablets each). It is distributed by American Health Packaging, Columbus, Ohio. The label includes NDC 60687-179-01 with instructions and storage information.*

FDA Label Image

15 mg Aripiprazole Tablet Blister

Packaging label for Aripiprazole Tablet, USP 15 mg, oral dosage form by American Health Packaging. The label includes lot number 123456 and expiry date 05/17, with barcodes and expiration information repeated for multiple tablets on the sheet.*

FDA Label Image

15 mg Aripiprazole Tablets Carton

Label for Aripiprazole tablets, USP, 15 mg, oral tablets packaged as 30 tablets (3 bottles of 10). The label shows the NDC number 60687-191-21 and indicates the product is Rx only. It includes storage instructions, a pharmacist dispensing note, safety warnings, and distributor information for American Health Packaging, Columbus, Ohio.*

FDA Label Image

2 mg Aripiprazole Tablet Blister

Packaging label for Aripiprazole Tablet USP 2 mg, distributed by American Health Packaging. The label includes the drug name, strength (2 mg), dosage form (tablet), lot number 123456, and expiry date 05/17. Multiple identical labels are shown on a single sheet, each with a barcode and regulatory information.*

FDA Label Image

2 mg Aripiprazole Tablets Carton

Aripiprazole 2 mg oral tablets label showing 30 tablets (3 x 10) supplied by American Health Packaging. The label includes dosage form, strength, quantity, NDC number, and pharmacy dispensing instructions. Storage conditions and safety warnings are also provided.*

FDA Label Image

20 mg Aripiprazole Tablet Blister

Multiple folded labels for Aripiprazole 20 mg oral tablets, USP. Each label includes the brand and generic name, strength (20 mg), dosage form (tablet), lot number 123456, and expiry date 05/17. The labels feature barcodes and identify American Health Packaging as the labeler based in California, USA.*

FDA Label Image

20 mg Aripiprazole Tablets Carton

The label for Aripiprazole tablets, USP, 20 mg strength, containing 30 tablets (3 bottles of 10 each). The label includes the NDC number 60687-202-21, states Rx only, and provides storage instructions. It is distributed by American Health Packaging in Columbus, Ohio. Additional details include pharmacist dispensing instructions and a note to keep the drug out of reach of children.*

FDA Label Image

30 mg Aripiprazole Tablet Blister

Aripiprazole 30 mg tablet USP labels for oral administration presented in a sheet format. Each label includes the drug name, strength, lot number (123456), expiry date (05/17), a barcode, and the labeler American Health Packaging. The labels are designed for individual tablet packaging.*

FDA Label Image

30 mg Aripiprazole Tablets Carton

Aripiprazole 30 mg tablets label from American Health Packaging, containing 30 tablets (3 strips of 10). The label includes the NDC 60687-213-21, usage instructions, pharmacist dispensing information, and storage conditions. The label indicates the product is prescription only and provides warnings regarding blister integrity and child safety.*

FDA Label Image

5 mg Aripiprazole Tablet Blister

Packaging label for Aripiprazole 5 mg oral tablets from American Health Packaging. The label includes the product name, dosage strength, dosage form, lot number (123456), and expiry date (03/17). The label is arranged in multiple identical stripes, each containing a barcode and labeling information.*

FDA Label Image

5 mg Aripiprazole Tablets Carton

Label for Aripiprazole Tablets, USP, 5 mg strength, in a package containing 100 tablets (10 x 10). The label shows the NDC code 60687-168-01 and is distributed by American Health Packaging. It includes pharmacist dispensing instructions and storage conditions, along with a barcode.*

FDA Label Image

78d2ec83 C576 1eb1 E053 2a91aa0aa179

Aripiprazole 5 mg oral tablet by American Health Packaging. The round, white tablet is imprinted with 'I' on one side and '98' on the other side, corresponding to the 5 mg strength.*

FDA Label Image

78d2efc3 976a 208d E053 2991aa0ab5d9

Aripiprazole 10 mg oral tablet, round and peach-colored, imprinted with 'I' on one side and '99' on the other. Manufactured by American Health Packaging.*

FDA Label Image

78d2efc3 976b 208d E053 2991aa0ab5d9

Aripiprazole 10 mg oral tablet shown as a round, yellow tablet with imprint 'I' on one side and '97' on the other. Manufactured by American Health Packaging.*

FDA Label Image

78d2efc3 976c 208d E053 2991aa0ab5d9

Aripiprazole oral tablet imprinted with "I" on one side and "96" on the other. The tablet is oblong and light brown, consistent with available Aripiprazole tablet strengths by American Health Packaging.*

FDA Label Image

78d2efc3 9770 208d E053 2991aa0ab5d9

Aripiprazole 10 mg oral tablet, light blue, capsule-shaped with imprint 'I' on one side and '95' on the other side. Labeled by American Health Packaging.*

FDA Label Image

78d2efc3 9771 208d E053 2991aa0ab5d9

Aripiprazole 15 mg tablet, an oval green oral tablet, embossed with 'I' on one side and '15' on the other. This strength is part of the Aripiprazole tablet line labeled by American Health Packaging.*

FDA Label Image

Figure-6 (Figure 6)

A Kaplan-Meier curve chart comparing the proportion of relapse over time between Aripiprazole and placebo groups. The x-axis represents days from randomization up to 182 days, and the y-axis shows the proportion with relapse. The chart includes the number of subjects at risk at various time points for each group.*

FDA Label Image

Figure1 (Figure1)

A chart titled 'Effect of Other Drugs on Aripiprazole' showing fold changes and 90% confidence intervals for pharmacokinetic parameters AUC and Cmax of aripiprazole. The chart compares the impact of various inhibitors, inducers, gastric acid blockers, and other drugs relative to a reference without interacting drugs, with values ranging from 0.0 to 3.0 fold change.*

FDA Label Image

Figure2 (Figure2)

A pharmacokinetic chart titled 'Effect of Other Drugs on Aripiprazole' showing the fold change and 90% confidence intervals of Dehydro-Aripiprazole with various interacting drugs. The x-axis represents change relative to reference without interacting drug, ranging from 0 to 3. The y-axis lists drug classes and examples, including CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, gastric acid blockers famotidine, and others such as valproate, lithium, and lorazepam. Data points show changes in AUC and Cmax parameters.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart illustrating the effect of Aripiprazole on various other drugs. The x-axis shows the fold change relative to a reference without interacting drug, ranging from 0.5 to 3.0. The y-axis lists different drugs and related pharmacokinetic parameters including CYP2D6 substrates (dextromethorphan), CYP2C9, CYP2C19 substrates (S-warfarin, R-warfarin), omeprazole, lamotrigine, valproate, lithium, lorazepam, and venlafaxine including its metabolites. Each line shows fold change and 90% confidence intervals for parameters like AUC, Cmax, INR, and DMDRP.*

FDA Label Image

Figure4 (Figure4)

A chart titled 'Aripiprazole Fold Change and 90% CI' displaying pharmacokinetic data for Aripiprazole in special populations. The x-axis shows 'Change Relative to Reference' from 0.5 to 3.0, and the y-axis lists groups based on CYP2D6 metabolizer status, gender, age, hepatic impairment severity, and severe renal impairment. The chart presents AUC and Cmax fold changes with error bars comparing these groups to reference populations.*

FDA Label Image

Figure5 (Figure5)

A pharmacokinetic chart depicting the fold change and 90% confidence intervals of dehydro-aripiprazole levels relative to reference across different variables such as CYP2D6 metabolizer status, gender, age groups, hepatic impairment severity, and severe renal impairment. The x-axis represents the change relative to reference, while the y-axis lists the different factor comparisons with AUC and Cmax values.*

FDA Label Image

Structure (Structure)

Chemical structure of aripiprazole shown as a 2D molecular diagram featuring rings, nitrogen atoms, chlorine substituents, and oxygen atoms in its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.